It is crucial to understand the drug development process and the many milestones and tasks that are essential to a comprehensive development plan to guarantee scientific and commercial success. While ...

Systemic risks are driving regulatory initiatives aimed at strengthening financial requirements. The following developments ...

OIRA — the Office of Information and Regulatory Affairs — is an obscure, but powerful federal office around the corner from the White House. President Trump has decided that it should get even more ...

WASHINGTON--(BUSINESS WIRE)--The Nuclear Company, which is pioneering the modernization of nuclear construction and leading fleet-scale deployment of nuclear power across America, today announced the ...

Philip Desjardins, most recently vice president of global regulatory affairs with Johnson & Johnson, has rejoined Arnold & Porter Kaye Scholer as a partner in its life sciences and health care ...